1Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [ J]. Lancet,2004,364(9434) :583 - 591.
2Moses JW, Leon MB, Popma J J, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J]. N Engl J Med,2003,349(14) :1315 - 1323.
3Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo ledions in small native enronaty arteries (C-SIRIUS) [ J]. J Am Coil Cardiol ,2004 ,43 (6) :1110 -1115.
4Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release,polymer-based, paclitaxel-eluting TAXUS stent : the TAXUS-IV trial[ J ]. Circulation,2004,109 ( 16 ) : 1942 - 1947.
5Moriee MC,Serrays PW ,Sousa JE,et al. A randomized comparison of a sirolimus--eluting stent with a stent for coronary revaseularization[J]. N Engl J Med,2002,346(23) : 1773 -1780.
6Gallo R,Padurean A,Jayaraman T,et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targering regulators of the cell cycle[J]. Circulation, 1999,99 (16) :2164 -2170.
1Danzi GB, Sesana M, Capuano C, et al. Long-term clinical outcomes after coronary angioplasty using long stents in small coronary vessels. Catheter Cardiovasc Interv, 2002,56:300-304.
2Shen WF, Zhang RY, Shen Y, et al. Optimal timing for coronary stenting in unstable angina. Chin Med J, 2001,114:59-61.
3Thomas JR, Wiliam jBB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. Circulation,1993,88:2987-3006.
4Serruys PW, De JP, Kiemenij F, et al. For the Benestent study group. A comparison of balloon-expandable stent implicatation with balloon angioplasty in patients with coronary artery disease. N Engl J Med,1994,331:489-495.
5Yoshitomi Y, Kojima S, Yano M, et al. Does stent design affect probability of restenosis? A randomized trial comparing multilink stents with GFX stents. Am Heart J, 2001,142:445-451.
